Ligand Pharmaceuticals, Inc. (LGND)
210.86
+3.06
(+1.47%)
USD |
NASDAQ |
Mar 17, 16:00
210.86
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Profit Margin (Quarterly) : 75.06% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.91% |
| ADMA Biologics, Inc. | 35.48% |
| Merck & Co., Inc. | 18.15% |
| Globus Medical, Inc. | 17.01% |
| Establishment Labs Holdings, Inc. | -4.05% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.07% |
| Return on Assets | 10.67% |
| Return on Invested Capital | 11.65% |
| Gross Profit Margin (Quarterly) | 81.42% |
| Operating Margin (Quarterly) | 33.59% |
| Return on Net Operating Assets | 20.16% |